NWI Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NWI Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-187,616	Closed	-$20.6M	–	56
2021 Q3	$20.6M	Hold	187,616	–	–	1.27%	18
2021 Q2	$17.6M	Hold	187,616	–	–	1.08%	24
2021 Q1	$17.3M	Hold	187,616	–	–	1.44%	20
2020 Q4	$13.7M	Buy	187,616 +117,616	+168%	+$8.74M	1.36%	20
2020 Q3	$5.44M	Buy	+70,000	New	+$4.82M	0.47%	26

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NWI Management's HZNP Position: Q4 2021 in Review

NWI Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2021, closing a stake of 187,616 shares — an estimated $20.6M sold.

NWI Management first reported a position in HZNP in Q3 2020 and held it in 5 quarters. The position peaked at $20.6M in Q3 2021. 611 funds tracked by Wall St. Rank hold HZNP as of Q4 2021.

NWI Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2021 after selling out during the quarter.
NWI Management sold 187,616 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2021, an estimated $20.6M.
NWI Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 5 quarters.
NWI Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $20.6M in Q3 2021.
611 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2021.

Based on NWI Management's 13F filing for Q4 2021, filed 14 Feb 2022.